Efficacy and safety of vinorelbine in heavily pretreated recurrent/metastatic head and neck squamous cell carcinoma patients

被引：1
|
作者：
Barth, Claire [1 ]
Naveau, Louise [1 ]
Touboul, Emmanuel [1 ]
Perie, Sophie [2 ]
Bamogho, Edith [1 ]
Haberer-Guillerm, Sophie [1 ]
Schlienger, Michel [1 ]
St Guily, Jean Lacau [2 ]
Huguet, Florence [1 ]
机构：
[1] Univ Paris 06, Tenon Hosp, HUEP, Dept Radiat Oncol, Paris, France
[2] Univ Paris 06, Tenon Hosp, HUEP, Dept Head & Neck Surg, Paris, France
来源：
ANTI-CANCER DRUGS | 2016年 / 27卷 / 04期
关键词：
vinorelbine; head and neck cancer; chemotherapy; recurrent; metastatic; PLATINUM-BASED CHEMOTHERAPY; PHASE-II TRIAL; METASTATIC HEAD; RECURRENT; CANCER; CARBOPLATIN; PACLITAXEL; CISPLATIN; CETUXIMAB; METHOTREXATE;
D O I：
10.1097/CAD.0000000000000333
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The aim of this study was to evaluate the efficacy and tolerance of vinorelbine as a single agent in the treatment of recurrent/metastatic head and neck squamous cell carcinoma. Patients were treated with oral or intravenous vinorelbine according to the pluridisciplinary tumor board's decision. Efficacy and safety outcomes were analyzed retrospectively. Twenty-three patients were included in the study. Sixteen patients (69%) had received at least two previous lines of chemotherapy. The disease control rate was 19%. The median progression-free survival was 2.6 months and the median overall survival was 3.4 months. The rate of grade 3-4 side effects was low (13%). Only one patient discontinued treatment because of side effects. Vinorelbine seems to be a well-tolerated regimen in heavily pretreated patients. However, this regimen does not seem to be efficient enough to be recommended.
引用
收藏
页码：349 / 352
页数：4
相关论文
共 50 条
  • [1] Efficacy and safety of capecitabine in heavily pretreated recurrent/metastatic head and neck squamous cell carcinoma
    Peron, Julien
    Poupart, Marc
    Ceruse, Philippe
    Ramade, Antoine
    Girodet, Didier
    Zrounba, Philippe
    Fayette, Jerome
    ANTI-CANCER DRUGS, 2012, 23 (10) : 1107 - 1111
  • [2] Apatinib for heavily pretreated recurrent and/or metastatic head and neck squamous cell carcinoma: Updated analysis
    Yang, K.
    Peng, G.
    Qin, Y.
    Huang, J.
    Ding, Q.
    Yang, Z.
    Dong, Y.
    Zhou, H.
    Cao, F.
    Chen, G.
    Zhu, L.
    ANNALS OF ONCOLOGY, 2021, 32 : S808 - S808
  • [3] Vinorelbine and carboplatin in recurrent and/or metastatic squamous cell carcinoma of the head and neck
    Kornek, V
    Scheithauer, W
    Glaser, C
    Toth, J
    Duman, M
    Formanek, M
    Hejna, M
    Kornfehl, J
    ONCOLOGY, 1999, 56 (01) : 24 - 27
  • [4] A phase II trial of vinorelbine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck
    Saxman, S
    Mann, B
    Canfield, V
    Loehrer, P
    Vokes, E
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1998, 21 (04): : 398 - 400
  • [5] Efficacy and safety of cisplatin and weekly docetaxel in patients with recurrent or metastatic squamous cell carcinoma of the head and neck
    Kim, Moon Jin
    Kim, Sung Min
    Jung, Hyun Ae
    Hong, Jung Yong
    Chang, Won Jin
    Choi, Moon Ki
    Kim, Hye Soak
    Sun, Jong-Mu
    Park, Keunchil
    Ahn, Myung-Ju
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2019, 34 (05): : 1107 - 1115
  • [6] Efficacy and safety of apatinib in heavily pretreated metastatic adenocarcinoma of the head and neck
    Gui, L.
    He, X.
    ANNALS OF ONCOLOGY, 2019, 30
  • [7] A phase II trial of cisplatin and vinorelbine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck
    Espinosa, E
    Zamora, P
    Millá, A
    Morales, S
    Molina, R
    Mira, M
    Barón, MG
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2002, 24 (12): : 1054 - 1059
  • [8] Efficacy and safety of pembrolizumab in Chinese patients with recurrent/unresectable/metastatic head and neck squamous cell carcinoma.
    Li, Jieying
    Song, Kai
    Feng, Yuanyong
    Shang, Wei
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18001 - E18001
  • [9] Safety and efficacy of temsirolimus in heavily pretreated patients with metastatic renal cell carcinoma
    Lamm, Wolfgang
    Vogl, Ursula Maria
    Bojic, Marija
    Zielinski, Christoph
    Klingler, Christoph
    Kramer, Gero
    Schmidinger, Manuela
    ACTA ONCOLOGICA, 2012, 51 (01) : 101 - 106
  • [10] Phase II study of vinorelbine (NVB) in patients with metastatic and/or recurrent squamous cell carcinoma of the head and neck (SCCHN)
    Degardin, M
    Bastit, P
    Rolland, F
    Armand, JP
    Chevallier, B
    VanGlabbeke, M
    Boudillet, J
    Tresca, P
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 843 - 843
12345